SkyQuest Technology Group recently introduced Biomarkers Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Biomarkers Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Biomarkers Market size was valued at USD 58.2 billion in 2023 and is poised to grow from USD 66.06 billion in 2024 to USD 181.92 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).
The biomarkers market has been witnessing significant growth in the past few years owing to rising cases of chronic illnesses, technological advancements, and the rising demand for personalized medicine. Presently, the number of patients suffering from chronic diseases is increasing on a global scale and this is majorly driving the demand for early detection, monitoring, and diagnosis, possible with biomarkers. Moreover, modernizations in proteomic, genomic, and metabolomics technologies improve the discovery and emergence of novel biomarkers. These factors are significantly driving the biomarkers market. However, the market is restrained by factors like the high cost of creating and validating biomarkers comprising major technology, research, and clinical trials. Also, low awareness of biomarkers and associated benefits offered will hamper the overall market growth. Nonetheless, the expansion of tailored medicine and extensive advances in technologies are a few opportunities seen in the biomarkers market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/biomarkers-market
The 2025 global Biomarkers Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Biomarkers Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Biomarkers Market Segments Analysis:
Global Biomarkers Market is segmented by Product, Type, Research Area, Technology, Disease Indication, Application, End User and region.
Based on Product, the market is segmented into Consumables, Services and Software. Based on Type, the market is segmented into Safety Biomarkers, Efficacy Biomarkers and Validation Biomarkers. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Technology, the market is segmented into Immunoassays, NGS, PCR, Mass Spectrometry, Chromatography and Other Technologies. Based on Disease Indication, the market is segmented into Cancer, Infectious Diseases, Immunological Disorders, Neurological Disorders, Cardiovascular Disorders and Other Disease Indications. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Clinical Research and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Biomarkers Market Regional Insights:
Region-wise, North America held maximum share of the market in the past years and is expected to hold dominant share in future as well due to the prevalence of advanced healthcare infrastructure and increasing investments in biomarkers for more advancements. Key nations like Canada and the United States hold a mature and well-developed healthcare infrastructure comprising better diagnostic laboratories, superior research facilities, and a strong healthcare system. This infrastructure aids extensive research and development of biomarkers. Also, heavy investments from both private and public sectors are propelling R&D in North America. The leading companies operating in the region include Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific, Agilent Technologies Inc., and more.
Top Market Players in Biomarkers Market are:
Hoffmann-La Roche AG (Switzerland)
Thermo Fisher Scientific Inc. (United States)
Agilent Technologies, Inc. (United States)
QIAGEN N.V. (Netherlands)
Bio-Rad Laboratories, Inc. (United States)
Merck & Co., Inc. (United States)
PerkinElmer, Inc. (United States)
Illumina, Inc. (United States)
BD (Becton, Dickinson and Company) (United States)
Myriad Genetics, Inc. (United States)
Siemens Healthineers AG (Germany)
Danaher Corporation (United States)
Biomerieux SA (France)
Waters Corporation (United States)
Abbott Laboratories (United States)
Sysmex Corporation (Japan)
Bio-Techne Corporation (United States)
Charles River Laboratories International, Inc. (United States)
Eurofins Scientific SE (Luxembourg)
Recent Developments:
In April 2024, Abbott declared that it received FDA clearance for its i-STAT TBI cartridge test to examine patients with doubted mild TBIs (traumatic brain injuries), also called ‘concussions’.
In July 2024, Thermo Fisher Scientific launched a novel CXCL10 testing service, which permits painless urine sample collection and examination with results obtained in less than 24 hours, offering data faster than the existing techniques used.
In April 2024, Bio-Rad Laboratories, Inc. introduced the ddPLEX ESR1 Mutation Detection Kit, its first ultra-sensitive multiplexed digital PCR (Polymerase Chain Reaction) assay. This assay increases the company’s offering of Droplet Digital PCR for oncology market, where such assays help therapy selection, translational research, and disease monitoring.
Also Read –
https://en.everybodywiki.com/Carbon
Forward-Looking Insights
The Biomarkers Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
